Cargando…
TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients
Tumor protein p73 (TP73) has been reported to be dysregulated in various types of human cancer and associated with clinical progression and outcome. Owing to the lack of reports on the correlation between TP73 protein expression and clinicopathologic features of cervical cancer, the aim of our resea...
Autores principales: | Ye, Hui, Guo, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682548/ https://www.ncbi.nlm.nih.gov/pubmed/31332036 http://dx.doi.org/10.1042/BSR20190095 |
Ejemplares similares
-
Long non-coding RNA TP73-AS1 predicts poor prognosis and regulates cell proliferation and migration in cervical cancer
por: Song, Zhijiao, et al.
Publicado: (2019) -
Clinical landscape of TP73 structural variants in ATL patients
por: Hiramatsu, Hiroaki, et al.
Publicado: (2023) -
Circulating TP73‐AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non‐small cell lung cancer
por: Yuan, Rong‐Xia, et al.
Publicado: (2022) -
Overexpressed TP73 induces apoptosis in medulloblastoma
por: Castellino, Robert C, et al.
Publicado: (2007) -
TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis
por: Chen, Caizhi, et al.
Publicado: (2022)